Literature DB >> 21525347

Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis.

Shweta S Puntambekar1, Cornelia C Bergmann, Carine Savarin, Christopher L Karp, Timothy W Phares, Gabriel I Parra, David R Hinton, Stephen A Stohlman.   

Abstract

Interleukin-10 (IL-10) mRNA is rapidly upregulated in the central nervous system (CNS) following infection with neurotropic coronavirus and remains elevated during persistent infection. Infection of transgenic IL-10/green fluorescent protein (GFP) reporter mice revealed that CNS-infiltrating T cells were the major source of IL-10, with minimal IL-10 production by macrophages and resident microglia. The proportions of IL-10-producing cells were initially similar in CD8(+) and CD4(+) T cells but diminished rapidly in CD8(+) T cells as the virus was controlled. Overall, the majority of IL-10-producing CD8(+) T cells were specific for the immunodominant major histocompatibility complex (MHC) class I epitope. Unlike CD8(+) T cells, a large proportion of CD4(+) T cells within the CNS retained IL-10 production throughout persistence. Furthermore, elevated frequencies of IL-10-producing CD4(+) T cells in the spinal cord supported preferential maintenance of IL-10 production at the site of viral persistence and tissue damage. IL-10 was produced primarily by the CD25(+) CD4(+) T cell subset during acute infection but prevailed in CD25(-) CD4(+) T cells during the transition to persistent infection and thereafter. Overall, these data demonstrate significant fluidity in the T-cell-mediated IL-10 response during viral encephalitis and persistence. While IL-10 production by CD8(+) T cells was limited primarily to the time of acute effector function, CD4(+) T cells continued to produce IL-10 throughout infection. Moreover, a shift from predominant IL-10 production by CD25(+) CD4(+) T cells to CD25(-) CD4(+) T cells suggests that a transition to nonclassical regulatory T cells precedes and is retained during CNS viral persistence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525347      PMCID: PMC3126516          DOI: 10.1128/JVI.00200-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells.

Authors:  M K Slifka; F Rodriguez; J L Whitton
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

2.  Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts.

Authors:  J D Sedgwick; A L Ford; E Foulcher; R Airriess
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

3.  Interleukin-10 determines viral clearance or persistence in vivo.

Authors:  David G Brooks; Matthew J Trifilo; Kurt H Edelmann; Luc Teyton; Dorian B McGavern; Michael B A Oldstone
Journal:  Nat Med       Date:  2006-10-15       Impact factor: 53.440

Review 4.  IL-10, T cell exhaustion and viral persistence.

Authors:  Shawn D Blackburn; E John Wherry
Journal:  Trends Microbiol       Date:  2007-03-01       Impact factor: 17.079

5.  The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis.

Authors:  M T Lin; D R Hinton; B Parra; S A Stohlman; R C van der Veen
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.616

Review 6.  T(H)1 cells control themselves by producing interleukin-10.

Authors:  Anne O'Garra; Paulo Vieira
Journal:  Nat Rev Immunol       Date:  2007-06       Impact factor: 53.106

7.  Resolution of a chronic viral infection after interleukin-10 receptor blockade.

Authors:  Mette Ejrnaes; Christophe M Filippi; Marianne M Martinic; Eleanor M Ling; Lisa M Togher; Shane Crotty; Matthias G von Herrath
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

8.  CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS.

Authors:  Shuen-Ing Tschen; Stephen A Stohlman; Chandran Ramakrishna; David R Hinton; Roscoe D Atkinson; Cornelia C Bergmann
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

Review 9.  Coronavirus infection of the central nervous system: host-virus stand-off.

Authors:  Cornelia C Bergmann; Thomas E Lane; Stephen A Stohlman
Journal:  Nat Rev Microbiol       Date:  2006-02       Impact factor: 60.633

10.  Mouse hepatitis virus pathogenesis in the central nervous system is independent of IL-15 and natural killer cells.

Authors:  Jun Zuo; Stephen A Stohlman; Jason B Hoskin; David R Hinton; Roscoe Atkinson; Cornelia C Bergmann
Journal:  Virology       Date:  2006-02-28       Impact factor: 3.616

View more
  26 in total

1.  Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

2.  Suppressors of cytokine signaling 1 and 3 are upregulated in brain resident cells in response to virus-induced inflammation of the central nervous system via at least two distinctive pathways.

Authors:  Maria Abildgaard Steffensen; Christina Fenger; Jeanette Erbo Christensen; Carina Krogsgaard Jørgensen; Maria Rosaria Bassi; Jan Pravsgaard Christensen; Bente Finsen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

3.  Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis.

Authors:  Niranjan Butchi; Parul Kapil; Shweta Puntambekar; Stephen A Stohlman; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

4.  Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.

Authors:  Jeffrey R Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.

Authors:  Timothy W Phares; Krista D DiSano; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

6.  IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination.

Authors:  Maria Teresa P de Aquino; Parul Kapil; David R Hinton; Timothy W Phares; Shweta S Puntambekar; Carine Savarin; Cornelia C Bergmann; Stephen A Stohlman
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.422

7.  Highly heterogeneous, activated, and short-lived regulatory T cells during chronic filarial infection.

Authors:  Simon Metenou; Yaya I Coulibaly; Daniel Sturdevant; Housseini Dolo; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Kishore Kanakabandi; Stephen F Porcella; Amy D Klion; Thomas B Nutman
Journal:  Eur J Immunol       Date:  2014-05-22       Impact factor: 5.532

Review 8.  Intrathecal humoral immunity to encephalitic RNA viruses.

Authors:  Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  Viruses       Date:  2013-02-15       Impact factor: 5.048

9.  IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis.

Authors:  Timothy W Phares; Krista D DiSano; David R Hinton; Mihyun Hwang; Allan J Zajac; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Neuroimmunol       Date:  2013-08-06       Impact factor: 3.478

10.  Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recovery.

Authors:  Carine Savarin; Cornelia C Bergmann; Melanie Gaignage; Stephen A Stohlman
Journal:  J Neuroinflammation       Date:  2015-11-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.